2 Patients with COVID-19 pneumonia managed in community settings

2 Patients with COVID-19 pneumonia managed in community settings

2.1 For patients with COVID-19 pneumonia managed in community settings:

  • assess the risks of VTE and bleeding

  • consider pharmacological prophylaxis if the risk of VTE outweighs the risk of bleeding (see recommendations¬†1.1 to 1.4).

For a short explanation of why we made this recommendation see the rationale section on patients with COVID-19 pneumonia managed in community settings.

Full details of the evidence and the panel's discussion are in the evidence reviews.